EZH2 and endometrial cancer: Additionally, the expression of various histone modifying enzymes are altered in endometrial cancer, including histone deacetylases as well as the histone methyltranferase EZH2. Their inhibition decreases proliferation and invasiveness in endometrial cancer cell lines [11–14].